The present meta-analysis indicated that microbial therapies ameliorate hepatic steatosis by reducing the levels of lipid profiles (TC, TG, LDL-c, HDL-c), liver enzymes (ALT, AST, ALP, and GGT), and HOMAI-R. Here, GPT is linked to fatty liver disease.